Relay Therapeutics
+$0.32 (+1.10%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell RLAY and other stocks, options, and ETFs commission-free!
About RLAY
Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery.
CEO
Sanjiv K. Patel
Employees
159
Headquarters
Cambridge, Massachusetts
Founded
2015
RLAY Key Statistics
Market Cap
2.81B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
724.85K
High Today
$30.24
Low Today
$29.12
Open Price
$29.39
Volume
776.91K
52 Week High
$64.37
52 Week Low
$27.70
RLAY Earnings
-$3.00
-$0.49
$2.01
$4.52
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 13, After Hours